Norepinephrine Bitartrate Injection
Product Images NDC 43066-997

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 43066-997). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norepinephrine Structural Formula (Image 01)

Chemical structure diagram of norepinephrine bitartrate, showing the molecular composition including a benzene ring with hydroxyl groups, an amine side chain, and the bitartrate moiety with carboxyl and hydroxyl groups, along with a molecule of water.*

FDA Label Image

Norepinephrine Representative Container Label 43066-997-01 (Image 02)

Norepinephrine Bitartrate Injection, USP 4 mg/4 mL (1 mg/mL) single-dose vial label from Baxter Healthcare Company. The label indicates the product is for intravenous infusion only and must be diluted before use. It includes warnings about sulfites and instructions to protect from light. Manufactured in India by Baxter Healthcare Corporation, Deerfield, IL.*

FDA Label Image

Norepinephrine Representative Label 43066-997-10 1 Of 4 (Image 03)

Norepinephrine Bitartrate Injection, USP 1 mg/mL in a 4 mg/4 mL dosage form. The label shows this intravenous injection is for sterile use, with a package containing 10 single-dose 4 mL vials. It is manufactured by Baxter Healthcare Company and includes warnings about dosage control, extravasation, and protection from light.*

FDA Label Image

Norepinephrine Representative Label 43066-997-10 2 Of 4 (Image 04)

Norepinephrine Bitartrate Injection, USP label showing 4 mg/4 mL (1 mg/mL) strength. Manufactured for Baxter Healthcare Corporation, Deerfield, IL. The label includes the NDC 43066-997-10 and indicates the product is made in India. The label is primarily white with the concentration indicated in a red circle.*

FDA Label Image

Norepinephrine Representative Label 43066-997-10 3 Of 4 (Image 05)

Text panel for Norepinephrine Bitartrate injection describing concentration (1 mg per mL norepinephrine base), presence of sodium chloride and sodium metabisulfite, caution about color and precipitate, storage instructions (20° to 25°C, excursions permitted between 15° to 30°C), and disposal instructions. Advises consulting package insert for usual dosage and dilution information.*

FDA Label Image

Norepinephrine Representative Label 43066-997-10 4 Of 4 (Image 06)

Label for Norepinephrine Bitartrate Injection, USP by Baxter Healthcare Company. The injection strength is 4 mg/4 mL (1 mg/mL). The label shows the NDC 43066-997-10 and includes a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.